Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Total Liabilities (2019 - 2025)

Historic Total Liabilities for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $137.5 million.

  • Outset Medical's Total Liabilities fell 4475.61% to $137.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $137.5 million, marking a year-over-year decrease of 4475.61%. This contributed to the annual value of $137.5 million for FY2025, which is 4475.61% down from last year.
  • Per Outset Medical's latest filing, its Total Liabilities stood at $137.5 million for Q4 2025, which was down 4475.61% from $134.9 million recorded in Q3 2025.
  • Outset Medical's 5-year Total Liabilities high stood at $253.0 million for Q1 2024, and its period low was $73.2 million during Q1 2021.
  • In the last 5 years, Outset Medical's Total Liabilities had a median value of $136.2 million in 2025 and averaged $145.4 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 7795.38% in 2021, then soared by 7950.8% in 2023.
  • Over the past 5 years, Outset Medical's Total Liabilities (Quarter) stood at $89.4 million in 2021, then surged by 72.43% to $154.1 million in 2022, then rose by 23.87% to $190.9 million in 2023, then soared by 30.41% to $249.0 million in 2024, then plummeted by 44.76% to $137.5 million in 2025.
  • Its last three reported values are $137.5 million in Q4 2025, $134.9 million for Q3 2025, and $134.0 million during Q2 2025.